PMC:7443692 / 1283-1593 JSONTXT

{"project":"LitCovid-sample-CHEBI","denotations":[{"id":"T8","span":{"begin":258,"end":265},"obj":"Chemical"}],"attributes":[{"id":"A8","pred":"chebi_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"}],"text":"eneity is defined at 22 sites of SARS-CoV-2 Spike\n• Six sites of N-linked microheterogeneity of human ACE2 receptor are described\n• Molecular dynamics simulations of Spike and ACE2 show essential roles for glycosylation\n• We uncover roles for variants in protein-glycan and glycan-glycan interactions\n\nCombi"}

{"project":"LitCovid-sample-PD-NCBITaxon","denotations":[{"id":"T6","span":{"begin":33,"end":43},"obj":"Species"},{"id":"T7","span":{"begin":97,"end":102},"obj":"Species"}],"attributes":[{"id":"A6","pred":"ncbi_taxonomy_id","subj":"T6","obj":"NCBItxid:2697049"},{"id":"A7","pred":"ncbi_taxonomy_id","subj":"T7","obj":"NCBItxid:9606"}],"namespaces":[{"prefix":"NCBItxid","uri":"http://purl.bioontology.org/ontology/NCBITAXON/"}],"text":"eneity is defined at 22 sites of SARS-CoV-2 Spike\n• Six sites of N-linked microheterogeneity of human ACE2 receptor are described\n• Molecular dynamics simulations of Spike and ACE2 show essential roles for glycosylation\n• We uncover roles for variants in protein-glycan and glycan-glycan interactions\n\nCombi"}

{"project":"LitCovid-sample-sentences","denotations":[{"id":"T12","span":{"begin":50,"end":130},"obj":"Sentence"},{"id":"T13","span":{"begin":131,"end":221},"obj":"Sentence"},{"id":"T14","span":{"begin":222,"end":303},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"eneity is defined at 22 sites of SARS-CoV-2 Spike\n• Six sites of N-linked microheterogeneity of human ACE2 receptor are described\n• Molecular dynamics simulations of Spike and ACE2 show essential roles for glycosylation\n• We uncover roles for variants in protein-glycan and glycan-glycan interactions\n\nCombi"}

{"project":"LitCovid-sample-PD-MONDO","denotations":[{"id":"T4","span":{"begin":33,"end":43},"obj":"Disease"}],"attributes":[{"id":"A4","pred":"mondo_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"eneity is defined at 22 sites of SARS-CoV-2 Spike\n• Six sites of N-linked microheterogeneity of human ACE2 receptor are described\n• Molecular dynamics simulations of Spike and ACE2 show essential roles for glycosylation\n• We uncover roles for variants in protein-glycan and glycan-glycan interactions\n\nCombi"}

{"project":"LitCovid-sample-UniProt","denotations":[{"id":"T277","span":{"begin":103,"end":107},"obj":"Protein"},{"id":"T278","span":{"begin":178,"end":182},"obj":"Protein"}],"attributes":[{"id":"A277","pred":"uniprot_id","subj":"T277","obj":"https://www.uniprot.org/uniprot/Q9UFZ6"},{"id":"A278","pred":"uniprot_id","subj":"T278","obj":"https://www.uniprot.org/uniprot/Q9UFZ6"}],"text":"eneity is defined at 22 sites of SARS-CoV-2 Spike\n• Six sites of N-linked microheterogeneity of human ACE2 receptor are described\n• Molecular dynamics simulations of Spike and ACE2 show essential roles for glycosylation\n• We uncover roles for variants in protein-glycan and glycan-glycan interactions\n\nCombi"}

{"project":"LitCovid-sample-PD-IDO","denotations":[{"id":"T8","span":{"begin":24,"end":29},"obj":"http://purl.obolibrary.org/obo/BFO_0000029"},{"id":"T9","span":{"begin":57,"end":62},"obj":"http://purl.obolibrary.org/obo/BFO_0000029"}],"text":"eneity is defined at 22 sites of SARS-CoV-2 Spike\n• Six sites of N-linked microheterogeneity of human ACE2 receptor are described\n• Molecular dynamics simulations of Spike and ACE2 show essential roles for glycosylation\n• We uncover roles for variants in protein-glycan and glycan-glycan interactions\n\nCombi"}

{"project":"LitCovid-sample-PD-FMA","denotations":[{"id":"T9","span":{"begin":258,"end":265},"obj":"Body_part"}],"attributes":[{"id":"A9","pred":"fma_id","subj":"T9","obj":"http://purl.org/sig/ont/fma/fma67257"}],"text":"eneity is defined at 22 sites of SARS-CoV-2 Spike\n• Six sites of N-linked microheterogeneity of human ACE2 receptor are described\n• Molecular dynamics simulations of Spike and ACE2 show essential roles for glycosylation\n• We uncover roles for variants in protein-glycan and glycan-glycan interactions\n\nCombi"}

{"project":"LitCovid-sample-PD-GO-BP-0","denotations":[{"id":"T5","span":{"begin":208,"end":221},"obj":"http://purl.obolibrary.org/obo/GO_0070085"}],"text":"eneity is defined at 22 sites of SARS-CoV-2 Spike\n• Six sites of N-linked microheterogeneity of human ACE2 receptor are described\n• Molecular dynamics simulations of Spike and ACE2 show essential roles for glycosylation\n• We uncover roles for variants in protein-glycan and glycan-glycan interactions\n\nCombi"}

{"project":"LitCovid-sample-GO-BP","denotations":[{"id":"T5","span":{"begin":208,"end":221},"obj":"http://purl.obolibrary.org/obo/GO_0070085"}],"text":"eneity is defined at 22 sites of SARS-CoV-2 Spike\n• Six sites of N-linked microheterogeneity of human ACE2 receptor are described\n• Molecular dynamics simulations of Spike and ACE2 show essential roles for glycosylation\n• We uncover roles for variants in protein-glycan and glycan-glycan interactions\n\nCombi"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T26","span":{"begin":33,"end":43},"obj":"SP_7"},{"id":"T27","span":{"begin":97,"end":102},"obj":"SP_6;NCBITaxon:9606;PG_10"},{"id":"T28","span":{"begin":103,"end":107},"obj":"PG_10;PR:000003622"},{"id":"T29","span":{"begin":178,"end":182},"obj":"G_3;PG_10;PR:000003622"},{"id":"T30","span":{"begin":266,"end":272},"obj":"CHEBI:17089;CHEBI:17089"},{"id":"T31","span":{"begin":277,"end":283},"obj":"CHEBI:17089;CHEBI:17089"},{"id":"T32","span":{"begin":284,"end":290},"obj":"CHEBI:17089;CHEBI:17089"}],"text":"eneity is defined at 22 sites of SARS-CoV-2 Spike\n• Six sites of N-linked microheterogeneity of human ACE2 receptor are described\n• Molecular dynamics simulations of Spike and ACE2 show essential roles for glycosylation\n• We uncover roles for variants in protein-glycan and glycan-glycan interactions\n\nCombi"}